Oruka Therapeutics, Inc. · NASDAQ:ORKA

Quinlan Paul T sold 733 Oruka Therapeutics, Inc. shares (Form 4)

Traded Jun 15, 2026 · Filed Jun 15, 2026

On Jun 15, 2026, Quinlan Paul T (General Counsel) sold 733 Oruka Therapeutics, Inc. shares at US$69.69 for US$51,083, leaving 31,034 shares. Filed Jun 15, 2026 (Form 4).

Sold
733 shares
Price
US$69.69
Value
US$51,083
Holding after
31,034 shares
Trading plan
No
Role
General Counsel

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 15, 2026Common StockSale733US$69.6931,034Direct

Source

View original at SEC

Related